Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Joint Outcome Study Continuation for Children With Severe Factor VIII Deficiency (JOSC)

This study is enrolling participants by invitation only.
Sponsor:
Collaborators:
Bayer
Rush University Medical Center
Phoenix Children's Hospital
The University of Texas Health Science Center, Houston
Oregon Health and Science University
Emory University
University of Texas Southwestern Medical Center
Palmetto Health
Indiana University School of Medicine
Intermountain Health Care, Inc.
Ann & Robert H Lurie Children's Hospital of Chicago
Information provided by (Responsible Party):
University of Colorado, Denver
ClinicalTrials.gov Identifier:
NCT01000844
First received: October 22, 2009
Last updated: June 15, 2016
Last verified: June 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is enrolling participants by invitation only.
  Estimated Study Completion Date: January 2020
  Estimated Primary Completion Date: January 2019 (Final data collection date for primary outcome measure)